Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria.

Maurer, M; Altrichter, S; Metz, M; Zuberbier, T; Church, M K; Bergmann, K-C

Maurer, M; Altrichter, S; Metz, M; Zuberbier, T; Church, M K; Bergmann, K-C.

Affiliation

Maurer M; Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Altrichter S; Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Metz M; Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Zuberbier T; Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Church MK; Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Bergmann KC; Department of Dermatology and Allergy, Charité - Universitätsmedizin Berlin, Berlin, Germany.

J Eur Acad Dermatol Venereol ; 32(3): e112-e113, 2018 Mar.

Article in En | MEDLINE | ID: mdl-28924988

Subject(s)

Anti-Asthmatic Agents/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Cold Temperature; Urticaria/drug therapy; Adult; Asthma/complications; Asthma/drug therapy; Chronic Disease; Female; Humans; Treatment Outcome; Urticaria/etiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Cold Temperature / Anti-Asthmatic Agents / Antibodies, Monoclonal, Humanized Type of study: Etiology_studies Limits: Adult / Female / Humans Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2018 Document type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google